Meet The Board
Dr. DeFranco studied Applied Physics at Cornell University under Professor George Malliaras and developed the fundamental organic electronics patterning technology as part of his PhD research. He decided to spin out the technology in 2009 and formed Orthogonal. Since then he has been the technical lead of the company. He is an author on 23 journal articles (1900+ citations) and has 16 patents.
In addition to prominent membership on Orthogonal’s Board of Directors, Cameron Piron is an industry-recognized leader and innovator in image-guided surgery.
Prior to co-founding Synaptive Medical, Cameron was president and co-founder of Sentinelle Medical, a medical device company that developed and manufactured advanced MRI-based breast imaging technologies. Sentinelle grew to over 200 employees and over $20 million in revenues before being acquired by Hologic, Inc. in 2010.
Cameron studied systems design engineering at the University of Waterloo, followed by a graduate degree at the University of Toronto in medical biophysics. His awards include the Ontario Premier’s Catalyst Award for Best Young Innovator in 2008; the University of Waterloo’s Alumni Achievement medal in 2009 for leading Sentinelle Medical in researching and manufacturing leading-edge MRI technologies that allow physicians to diagnose breast cancer and other medical conditions faster and more accurately; being named to Canada’s Top 40 Under 40™ list in 2009, which was established by Caldwell Partners and celebrates the achievements of young Canadians in the private, public and non-profit sectors; and being the first Canadian ever to win R&D Magazine’s Innovator of the Year award in 2008.
In 2015, Cameron was named one of Fast Company’s Most Creative People, was recognized for his leadership in 2016 when Synaptive was named Life Sciences Ontario’s Company of the Year, and was named a finalist for the 2017 Bloom Burton Award in recognition of his contributions to the Canadian healthcare industry. He is a member of Synaptive’s Board of Directors, as well as those of equally disruptive technology innovators, Conavi and Coramed.
Brad Schmidt is the CEO of Panaxium, a Bioelectronic Medicine company working towards fundamentally change the way neurological disorders are treated leveraging the use of organic bioelectronic materials to develop micro-scale implants.
Prior to Panaxium, Brad was the CEO of Tornado Spectral Systems Inc., which develops instruments for real-time chemical identification in manufacturing, and previously Brad was a management consultant with the firm McKinsey & Company, advising senior management at Fortune-500 companies in a variety of industries including Retail, Transportation, Energy, and Public Economic Development.
Dr. Schmidt has a PhD in Electrical and Computer Engineering from Cornell University, where his research was focused on Nanobiotechnology & Integrated Silicon Photonics. He holds Bachelor’s and Master’s degrees in Applied and Engineering Physics, also from Cornell.
Ben Gallacher is the President & CEO as well as the co-founder of Performance Phenomics Inc. where he oversees all business and operations in the company. He is a director of Orthogonal, Panaxium and Archeoptix. He is an active angel and venture investor.
Ben is actively involved in the Lace Em’ Up Foundation for Kids, a charity which helps financially disadvantaged kids play organized hockey. He was an NHL draft pick in 2010 and a scholar athlete in Hockey East and played 4 years of Division 1 NCAA hockey graduating from the Isenberg School of Management at the University of Massachusetts Amherst.
TK PEN is founder of TPV Technology, world’s largest PC monitor producer which he sold in 2005. He has private investments in 20 different display related companies. He is also chairman of Orient Golf International and China LPGA Tour.
Contact us at: email@example.com